Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00332085 · ClinicalTrials.gov registry record · Phase 1
Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes
A Phase 1 study, sponsored by Bastyr University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT00332085 is a Phase 1 study that was terminated before completion, run by Bastyr University. The registered enrollment target is 40 participants.
The verdict
NCT00332085, a Phase 1 study, was terminated before completion, sponsored by Bastyr University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
This pilot trial seeks to gather preliminary data on the combination of chromium picolinate, the most commonly used form of chromium, and metformin. The trial will recruit type 2 diabetes subjects already on metformin and treat them with chromium for 8 weeks. The results of this trial will provide vital preliminary data including safety and size of effect to direct future studies.
Interventions
- DRUG Chromium Picolinate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-01 |
| Est. Completion | 2007-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00332085
The ClinicalTrials.gov registry entry for NCT00332085 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bastyr University, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chromium Picolinate is the first listed.
NCT00332085 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00332085 about?
NCT00332085 is a clinical study titled "Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes". This pilot trial seeks to gather preliminary data on the combination of chromium picolinate, the most commonly used form of chromium, and metformin. The trial will recruit type 2 diabetes subjects already on metformin and treat them with chromium for 8 weeks. The results of this trial will provide v...
What is the current status of trial NCT00332085?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2006-01. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00332085?
The interventions under investigation include: Chromium Picolinate (DRUG).
Who is sponsoring clinical trial NCT00332085?
This trial is sponsored by Bastyr University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.